Average Co-Inventor Count = 7.88
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (29 from 3,923 patents)
2. Pharmacyclics, Inc. (7 from 193 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (1 from 245 patents)
4. Irm LLC (1 from 151 patents)
5. Cytovia, Inc. (1 from 47 patents)
38 patents:
1. 12209098 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
2. 11952386 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
3. 11931363 - Triazolopyrimidine compounds and uses thereof
4. 11905283 - Compounds and compositions for inhibiting the activity of SHP2
5. 11207325 - Triazolopyrimidine compounds and uses thereof
6. 10968235 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
7. 10934285 - Compounds and compositions for inhibiting the activity of SHP2
8. 10689378 - Triazolopyridine compounds and uses thereof
9. 10676479 - Imidazolepyridine compounds and uses thereof
10. 10336774 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
11. 10308660 - Compounds and compositions for inhibiting the activity of SHP2
12. 10301278 - 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
13. 10287266 - Compounds and compositions for inhibiting the activity of SHP2
14. 10220036 - Triazolopyrimidine compounds and uses thereof
15. 10167279 - Compounds and compositions as RAF kinase inhibitors